Skip to main content

Table 2 Baseline characteristics of randomized patients (150 patients, divided into Groups A and B, to maintain blinding)

From: Probiotics: Prevention of Severe Pneumonia and Endotracheal Colonization Trial—PROSPECT: a pilot trial

 

Group A

Group B

Total

N = 78

N = 72

N = 150

Age (years), mean (standard deviation)

58.8 (17.0)

61.2 (15.4)

60.0 (16.3)

APACHE II, mean (standard deviation)

21.0 (8.4)

22.7 (7.3)

21.8 (7.9)

Female, n (%)

31 (39.7)

31 (43.1)

62 (41.3)

Type of patient, n (%)

   

 Medical

66 (84.6)

60 (83.3)

126 (84.0)

 Surgical

3 (3.8)

5 (6.9)

8 (5.3)

 Trauma

9 (11.5)

7 (9.7)

16 (10.7)

Admitting diagnosis, n (%)

   

 Cardiovascular

4 (5.1)

4 (5.6)

8 (5.3)

 Respiratory

35 (44.9)

26 (36.1)

61 (40.7)

 Gastrointestinal

2 (2.6)

0 (0.0)

2 (1.3)

 Neurologic

8 (10.3)

10 (13.9)

18 (12.0)

 Sepsis

16 (20.5)

17 (23.6)

33 (22.0)

 Trauma

7 (9.0)

7 (9.7)

14 (9.3)

 Metabolic

2 (2.6)

1 (1.4)

3 (2.0)

 Hematologic

1 (1.3)

0 (0.0)

1 (0.7)

 Renal

1 (1.3)

2 (2.8)

3 (2.0)

 Other medical

2 (2.6)

4 (5.6)

6 (4.0)

 Other surgical

0 (0.0)

1 (1.4)

1 (0.7)